As shown in Figs. 3, 8 and 9, finasteride or QC treatment profoundly inhibited the expression of cyclin D1 and Bcl-2 induced by the construction of the BPH model, at the transcriptional and translational levels. Here, BCL2 is linked to benign prostatic hyperplasia.